Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsPension (IS)Shares IssuedShares Outstanding
Ratios

BioLineRx (BLRX) Leases: 2023-2025

Historic Leases for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $800,000.

  • BioLineRx's Leases fell 44.90% to $800,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $800,000, marking a year-over-year decrease of 44.90%. This contributed to the annual value of $967,000 for FY2024, which is 31.66% down from last year.
  • Per BioLineRx's latest filing, its Leases stood at $800,000 for Q2 2025, which was down 7.30% from $863,000 recorded in Q1 2025.
  • BioLineRx's 5-year Leases high stood at $1.7 million for Q1 2023, and its period low was $800,000 during Q2 2025.
  • Its 3-year average for Leases is $1.3 million, with a median of $1.4 million in 2023.
  • Data for BioLineRx's Leases shows a maximum YoY slumped of 44.90% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows BioLineRx's Leases stood at $1.4 million in 2023, then plummeted by 31.66% to $967,000 in 2024, then tumbled by 44.90% to $800,000 in 2025.
  • Its Leases stands at $800,000 for Q2 2025, versus $863,000 for Q1 2025 and $967,000 for Q4 2024.